Can lexapro make depression worse
Pro Research Analysisby 
Searched over 200M research papers
Can Lexapro Make Depression Worse?
Introduction to Lexapro and Its Use in Depression Treatment
Lexapro, also known as escitalopram, is a selective serotonin reuptake inhibitor (SSRI) commonly prescribed for the treatment of major depressive disorder (MDD) and anxiety disorders. It has been shown to be effective and well-tolerated, with clinical trials demonstrating significant improvements in depressive symptoms compared to placebo 135.
Efficacy of Lexapro in Treating Depression
Multiple studies have confirmed the efficacy of Lexapro in reducing depressive symptoms. In a multicenter randomized, placebo-controlled double-blind study, patients treated with Lexapro showed significant improvements in depression scales such as the Hamilton Depression Rating Scale (HAM-D) and the Montgomery-Åsberg Depression Rating Scale (MADRS) compared to those receiving a placebo . Another study highlighted that Lexapro, both in its proprietary and generic forms, was effective in treating major depression, with similar efficacy and safety profiles .
Safety and Tolerability of Lexapro
Lexapro is generally well-tolerated, with most adverse events being mild and temporary. Common side effects include nausea, insomnia, and fatigue, but these are often comparable to those experienced with a placebo 15. In a study involving elderly patients, Lexapro combined with cognitive therapy significantly improved depression levels and quality of life without notable adverse reactions .
Potential for Increased Depression or Suicidality
Despite its efficacy, there is evidence suggesting that SSRIs, including Lexapro, may initially exacerbate depressive symptoms or increase suicidality in some patients. A study using fast-scan cyclic voltammetry in mice indicated that acute doses of Lexapro led to dynamic changes in serotonin levels, which could be clinically relevant to the increased depression or suicidality observed in some patients at the onset of treatment . This highlights the importance of careful monitoring during the initial stages of SSRI therapy.
Conclusion
While Lexapro is an effective and generally well-tolerated treatment for major depressive disorder, there is a potential risk for increased depression or suicidality, particularly at the beginning of treatment. This underscores the need for close monitoring by healthcare providers to ensure patient safety and optimal therapeutic outcomes.
Sources and full results
Most relevant research papers on this topic